Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 238,494 |
|
|||||
| News | - | ||||||
| Day High | 47.465 | Low High |
|||||
| Day Low | 44.52 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Apogee Therapeutics Inc | APGE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.27 | 2.77% | 47.13 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 46.17 | 44.52 | 47.465 | 47.13 | 45.86 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,416 | 238,494 | $ 46.27 | $ 11,035,885 | - | 14.19 - 72.29 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:20:01 | formt | 320 | $ 47.13 | USD |
Apogee Therapeutics (APGE) Options Flow Summary
Apogee Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.39B | 50.66M | - | 0 | -83.99M | -1.66 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Apogee Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APGE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 48.01 | 51.00 | 43.605 | 47.37 | 311,908 | -0.88 | -1.83% |
| 1 Month | 66.22 | 68.21 | 43.605 | 55.17 | 479,030 | -19.09 | -28.83% |
| 3 Months | 33.17 | 72.29 | 32.78 | 57.34 | 718,814 | 13.96 | 42.09% |
| 6 Months | 15.30 | 72.29 | 14.19 | 46.25 | 505,712 | 31.83 | 208.04% |
| 1 Year | 21.50 | 72.29 | 14.19 | 39.09 | 445,594 | 25.63 | 119.21% |
| 3 Years | 21.50 | 72.29 | 14.19 | 39.09 | 445,594 | 25.63 | 119.21% |
| 5 Years | 21.50 | 72.29 | 14.19 | 39.09 | 445,594 | 25.63 | 119.21% |
Apogee Therapeutics Description
| Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts. |
